CytomX Therapeutics CTMX
NASDAQ CTMX
$2.44 +0.04 (+1.67%)
At close: Oct 22, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Amortization of Deferred Charges (2014 - 2015)

Updated

Analysis

CytomX Therapeutics (CTMX) Amortization of Deferred Charges (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,139.85 Bn 1,108.44 Bn 19.71 Bn
2 Johnson & Johnson 634.68 Bn 554.54 Bn 17.30 Bn
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn
4 Merck 354.57 Bn 308.95 Bn 12.21 Bn
5 Novartis Ag 300.14 Bn 264.13 Bn 11.24 Bn
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn
7 Amgen 237.91 Bn 193.31 Bn 7.24 Bn
8 Gilead Sciences 193.96 Bn 168.15 Bn 6.22 Bn
9 Pfizer 170.07 Bn 116.71 Bn 10.94 Bn
10 CytomX Therapeutics 506.84 Mn -450.82 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2015 57,000.00
Jun 30, 2015 10,000.00
Mar 31, 2015 13,000.00
Dec 31, 2014 10,000.00
API Access

CytomX Therapeutics Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=CTMX&period=max&api_key=YOUR_API_KEY